Clinical Trial Update: Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating filgrastim or pegfilgrastim to prevent neutropenia in women undergoing chemotherapy after breast cancer surgery; current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Neutropenia

Drugs mentioned

• Filgrastim (filgrastim)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Anglo Celtic Cooperative Oncology Group | Conditions: Breast Cancer, Neutropenia | Phase 4 | Status: UNKNOWN